Valeo Pharma CEO credits Enerzair for strong position on Canadas top-growing companies list
–News Direct– Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) CEO Steve Saviuk joined Proactive's Stephen Gunnion to discuss the company's strong position on the Globe and Mail's Report on Business annual list of Canadas top-growing companies. The company placed 151 out of 425 companies, with a three-year growth rate of 322%. Saviuk explained that the rankings are calculated on revenue growth, and the exponential growth in the company's Enerzair asthma therapy helped it secure its position. Despite launching less than two years
Read more